In the British Medical Journal (BMJ), an interesting population based cohort study found that use of incretin based drugs (dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists) might be associated with an increased risk of cholangiocarcinoma (cancer of bile ducts) in adults with type 2 diabetes. While this certainly does not prove cause and effect, it is certainly an interesting finding. Please click below read more about this study and cholangiocarcinoma (cancer of bile duct).
Please share your thoughts and subscribe to receive my blogs.
#incretin #drugs #cancer
Follow me on Twitter and Facebook @ReecesPiecesDi and Instagram ReecesPiecesDI.